Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuances
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Long-Term Debt Issuances (2016 - 2024)

Historic Long-Term Debt Issuances for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 8 years, with Q3 2024 value amounting to $31.8 million.

  • Lifecore Biomedical, Inc. \De\'s Long-Term Debt Issuances changed N/A to $31.8 million in Q3 2024 from the same period last year, while for Aug 2024 it was $348.0 million, marking a year-over-year change of. This contributed to the annual value of $128.6 million for FY2025, which is 1405.14% down from last year.
  • According to the latest figures from Q3 2024, Lifecore Biomedical, Inc. \De\'s Long-Term Debt Issuances is $31.8 million.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Long-Term Debt Issuances ranged from a high of $150.0 million in Q1 2021 and a low of $20.0 million during Q2 2021
  • Its 4-year average for Long-Term Debt Issuances is $86.3 million, with a median of $89.2 million in 2023.
  • Per our database at Business Quant, Lifecore Biomedical, Inc. \De\'s Long-Term Debt Issuances changed by 0.0% in 2022 and then skyrocketed by 63316.5% in 2023.
  • Over the past 4 years, Lifecore Biomedical, Inc. \De\'s Long-Term Debt Issuances (Quarter) stood at $20.0 million in 2021, then changed by 0.0% to $20.0 million in 2022, then skyrocketed by 633.16% to $146.6 million in 2023, then tumbled by 78.3% to $31.8 million in 2024.
  • Its Long-Term Debt Issuances was $31.8 million in Q3 2024, compared to $149.6 million in Q2 2024 and $146.6 million in Q2 2023.